Suppr超能文献

乳腺癌筛查:我们走过了哪些历程,又将走向何方?基于历史、数据和经验的个人观点。

Breast cancer screening: Where have we been and where are we going? A personal perspective based on history, data and experience.

作者信息

Kopans Daniel B

机构信息

Radiology Harvard Medical School, Founder Bresat Imagning Division Massachusetts General Hospital, 20 Manitoba Road, Waban, MA 02468, United States.

出版信息

Clin Imaging. 2018 Jul-Aug;50:91-95. doi: 10.1016/j.clinimag.2017.12.013. Epub 2017 Dec 27.

Abstract

It is important to understand the history of breast cancer screening to better understand the continuing effort to reduce access to screening. Since the randomized, controlled trials have shown a statistically significant mortality reduction for women ages 40-74, the appropriate threshold for initiating screening is age 40 with no data to support the use of the age of 50 as a threshold for screening. All women are at risk for developing breast cancer and all women should have access to screening.

摘要

了解乳腺癌筛查的历史对于更好地理解为减少筛查机会所做的持续努力很重要。由于随机对照试验已显示40至74岁女性的死亡率在统计学上有显著降低,因此开始筛查的合适阈值是40岁,没有数据支持将50岁作为筛查阈值。所有女性都有患乳腺癌的风险,所有女性都应该有机会接受筛查。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验